is tirzepatide a glp-1 Pharmacogenomics of Tirzepatide: Genomic Insights into Dual GIP/GLP-1 Agonist Response in Type 2 Diabetes and Atherosclerosis Tirzepatide Associated with Lower POAG,
Description
Its important to remember that weight loss is a highly individual process, and responses to GLP-1 agonist medications vary from person to person
This called for further studies investigating modification of the GIP C-terminus on interaction with the GIP receptor
2023a, 2023b
PMID: 18200802
LIV Body is a technology company
